Articles
Media
All VideosCase Based Roundtable SeriesEyeviewsInsightsMedical World NewsPodcastsRapid ReadoutsViewpoints
Publications
Digital EditionSupplements And Featured Publications
Conferences
Conference Listing
More
CME/CE
Resources
SponsoredZEISS Clinical CasesZeiss Cataract InsightsZeiss Cataract DigitalizationEnhancing the Patient JourneyEYLEA 8mg for nAMD and DME TreatmentBetween the Lines

Subscribe

  • Articles
  • Media
  • Publications
  • Conferences
  • CME/CE
  • Resources
  • Subscribe
  • AMD
  • Cataract & Refractive
  • Cornea
  • Gene Therapy
  • Glaucoma
  • Inflammation & Infection
  • Paediatrics
  • Retina
Spotlight -
ZEISS Clinical Cases|
Heidelberg Engineering: Enhancing the Patient Journey
Advertisement

Andreas F. Borkenstein, MD

Advertisement

Articles by Andreas F. Borkenstein, MD

A pile of papers bound together with binder clips sits on a desk. Image credit: ©PaeGAG – stock.adobe.com

Case report: diversifying cataract outcomes

ByAndreas F. Borkenstein, MD
February 1st 2024

Many options with one single Nd:YAG laser

Focusing the battle against dry AMD

ByAndreas F. Borkenstein, MD
September 12th 2019

CATARACT SURGERIES IN CHALLENGING CASES: Choosing the CT LUCIA 621P IOL to optimize success in eyes with compromised zonules

ByAndreas F. Borkenstein, MD
November 8th 2018
Advertisement

Latest Updated Articles

  • CATARACT SURGERIES IN CHALLENGING CASES: Choosing the CT LUCIA 621P IOL to optimize success in eyes with compromised zonules
    CATARACT SURGERIES IN CHALLENGING CASES: Choosing the CT LUCIA 621P IOL to optimize success in eyes with compromised zonules

    Published: November 8th 2018 | Updated:

  • A pile of papers bound together with binder clips sits on a desk. Image credit: ©PaeGAG – stock.adobe.com
    Case report: diversifying cataract outcomes

    Published: February 1st 2024 | Updated:

  • Focusing the battle against dry AMD
    Focusing the battle against dry AMD

    Published: September 12th 2019 | Updated:



Advertisement
Advertisement

Trending on Ophthalmology Times Europe

1

Q&A: Jay Chhablani discusses analysis of retinal vasculitis events with intravitreal agents

2

Q&A: Margaret Chang on the phase 1 trial of OTX-TKI for diabetic retinopathy

  • Advertise
  • About Us
  • Editorial Info
  • Editorial Board
  • Contact Us
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us